VJHemOnc is committed to improving our service to you

SOHO 2020 | State of the art in CAR-T

VJHemOnc is committed to improving our service to you

Peter A. Riedell

Peter A. Riedell, MD, University of Chicago Medicine, Chicago, IL, provides an outlook in the current CAR-T climate and where things are moving towards in the future, including a better understanding of response, T-cell exhaution and CD19 antigen loss. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter